2009•Huazhong yixue zazhiRequires access

Intervention of participants with composite impaired glucose regulation and obesity by Metformin

Xiuhua Zhang

Open publisher page 1 citations

Abstract

Objective To observe the effects of intervention in participants with composite impaired glucose regulation and obesity by Metformin.Methods One hundred and sixty participants with impaired glucose regulation and obesity who were diagnosed by oral glucose tolerance test were randomly divided into control group and treatment group.Participants in control group received diabetic diet and physical training,and those in the treatment group were treated by Metformin sustained-releasing tablets(0.5 g,once every day) plus diabetic diet and physical training.Fasting plasma glucose(FPG),2hPG,body mass index(BMI),fasting insulin(FINS) and free fatty acid(FFA) were determined per 6 months during a follow-up period of 3 years for statistical analysis.Results The FPG,FINS,BMI,and FFA were markedly reduced after treatment in the treatment group(P0.05),and the 2hPG was reduced but had no statistically significant difference(P0.05).There was significant difference in each index in control group before and after treatment(P0.05).Condusion Metformin can prevent the development of impaired glucose regulation to type 2 diabetic mellitus by reducing the plasma glucose and BM,and improving the state of insulin resistance.Therefore,Metformin can prevent the morbidity of diabetes in the population with impaired glucose regulation and obesity.

About this research paper

What this paper is about

Objective To observe the effects of intervention in participants with composite impaired glucose regulation and obesity by Metformin.Methods One hundred and sixty participants with impaired glucose regulation and obesity who were diagnosed by oral glucose tolerance test were randomly divided into control group and treatment group.Participants in control group received diabetic diet and physical training,and those in the treatment group were treated by Metformin sustained-releasing tablets(0.5 g,once every day) plus diabetic diet and physical training.Fasting plasma glucose(FPG),2hPG,body mass index(BMI),fasting insulin(FINS) and free fatty acid(FFA) were determined per 6 months during a follow-up period of 3 years for statistical analysis.Results The FPG,FINS,BMI,and FFA were markedly reduced after treatment in the treatment group(P0.05),and the 2hPG was reduced but had no statistically significant difference(P0.05).There was significant difference in each index in control group before and after treatment(P0.05).Condusion Metformin can prevent the development of impaired glucose regulation to type 2 diabetic mellitus by reducing the plasma glucose and BM,and improving the state of insulin resistance.Therefore,Metformin can prevent the morbidity of diabetes in the population with impaired glucose regulation and obesity.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of intervention in participants with composite impaired glucose regulation and obesity by Metformin.Methods One hundred and sixty participants with impaired glucose regulation and obesity who were diagnosed by oral glucose tolerance test were randomly divided into control group and treatment group.Participants in control group received diabetic diet and physical training,and those in the treatment group were treated by Metformin sustained-releasing tablets(0.5 g,once every day) plus diabetic diet and physical training.Fasting plasma glucose(FPG),2hPG,body mass index(BMI),fasting insulin(FINS) and free fatty acid(FFA) were determined per 6 months during a follow-up period of 3 years for statistical analysis.Results The FPG,FINS,BMI,and FFA were markedly reduced after treatment in the treatment group(P0.05),and the 2hPG was reduced but had no statistically significant difference(P0.05).There was significant difference in each index in control group before and after treatment(P0.05).Condusion Metformin can prevent the development of impaired glucose regulation to type 2 diabetic mellitus by reducing the plasma glucose and BM,and improving the state of insulin resistance.Therefore,Metformin can prevent the morbidity of diabetes in the population with impaired glucose regulation and obesity.

Key concepts: Metformin, Medicine, Internal medicine, Impaired glucose tolerance, Obesity, Endocrinology, Insulin resistance, Body mass index

Related papers

Back to paper searchBrowse research topicsOriginal source
Intervention of participants with composite impaired glucose regulation and obesity by Metformin — Research Paper | ScholarLens